Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-d...

FDA Recall #D-0074-2021 — Class II — October 27, 2020

Recall #D-0074-2021 Date: October 27, 2020 Classification: Class II Status: Terminated

Product Description

Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77

Reason for Recall

Failed Dissolution Specification

Recalling Firm

Zydus Pharmaceuticals (USA) Inc — Pennington, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

6,840 units

Distribution

Distributed Nationwide in the USA

Code Information

Lot # M005681, EXP 3/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated